eteplirsen (Exondys 51) Report issue

Biologics Nucleic acid Orphan Drug FDA Approved FDA First in Class Fast Track FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH
Back

Drug Pricing Summary

VA Big4

$1222.1100 - $6110.5500

VA FSS

$1591.9600 - $7959.8000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
eteplirsen 50 mg / 1 mL (1 mL INJECTION) $1222.1100 VA Big4
  • Exondys 51 (1)
    		•  Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $1591.9600 VA FSS
  • Exondys 51 (1)
    		•  Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $6110.5500 VA Big4
  • Exondys 51 (1)
    		•  Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $7959.8000 VA FSS
  • Exondys 51 (1)
    		•  Sarepta Therapeutics Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue